Increased plasma serotonin in primary pulmonary hypertension
- PMID: 7653484
- DOI: 10.1016/s0002-9343(99)80156-9
Increased plasma serotonin in primary pulmonary hypertension
Abstract
Purpose: Pulmonary hypertension can occur in patients who have disorders associated with altered platelet serotonin storage, including collagen vascular disease and platelet storage pool disease. We tested the hypothesis that primary pulmonary hypertension (PPH) may be also associated with impaired handling of serotonin by platelets, resulting in increased plasma serotonin levels.
Patients and methods: We used radioenzymatic assays to measure serotonin in platelets and plasma and serotonin released during in vitro platelet aggregation in 16 patients with PPH, and in 16 normal controls matched for age and sex. Six patients were restudied after heart-lung transplantation to determine whether serotonin abnormalities persisted after pulmonary arterial pressure returned to normal.
Results: Patients had decreased platelet serotonin concentration (1.8 +/- 0.6 x 10(-18) mol/platelet versus 3.2 +/- 0.2 x 10(-18) mol/platelet in controls; P < 0.01) and increased plasma serotonin concentration (30.1 +/- 9.2 x 10(-9) mol/L versus 0.6 +/- 0.1 x 10(-9) mol/L in controls; P < 0.001). Serotonin released during in vitro platelet aggregation was higher in patients than in controls. After heart-lung transplantation, platelet serotonin concentrations remained decreased and plasma levels remained increased.
Conclusions: Abnormal handling of serotonin by platelets leading to an increase in plasma serotonin occurs in PPH. The persistent decrease in platelet storage of serotonin after heart-lung transplantation suggests that this platelet abnormality is not secondary to PPH.
Similar articles
-
High plasma serotonin levels in primary pulmonary hypertension. Effect of long-term epoprostenol (prostacyclin) therapy.Arterioscler Thromb Vasc Biol. 2000 Oct;20(10):2233-9. doi: 10.1161/01.atv.20.10.2233. Arterioscler Thromb Vasc Biol. 2000. PMID: 11031209 Clinical Trial.
-
Platelet serotonin content and transpulmonary platelet serotonin gradient in patients with pulmonary hypertension.Respiration. 2011;81(3):211-6. doi: 10.1159/000314271. Epub 2010 Apr 30. Respiration. 2011. PMID: 20431284
-
A role for potassium channels in smooth muscle cells and platelets in the etiology of primary pulmonary hypertension.Chest. 1998 Sep;114(3 Suppl):200S-204S. doi: 10.1378/chest.114.3_supplement.200s. Chest. 1998. PMID: 9741569 Review.
-
Pulmonary arterial hypertension and type-I glycogen-storage disease: the serotonin hypothesis.Eur Respir J. 2002 Jul;20(1):59-65. doi: 10.1183/09031936.02.00258702. Eur Respir J. 2002. PMID: 12166582
-
Age and the platelet serotonin vasoconstrictor axis in essential hypertension.J Cardiovasc Pharmacol. 1988;11 Suppl 1:S35-40. J Cardiovasc Pharmacol. 1988. PMID: 2459512 Review.
Cited by
-
Severe pulmonary hypertension in idiopathic nonspecific interstitial pneumonia.Pulm Circ. 2012 Jan-Mar;2(1):101-6. doi: 10.4103/2045-8932.94842. Pulm Circ. 2012. PMID: 22558525 Free PMC article.
-
Portopulmonary hypertension and hepatopulmonary syndrome: a clinician-oriented overview.Eur Respir Rev. 2012 Sep 1;21(125):223-33. doi: 10.1183/09059180.00007211. Eur Respir Rev. 2012. PMID: 22941887 Free PMC article.
-
Plasma serotonin levels are normal in pulmonary arterial hypertension.Pulm Pharmacol Ther. 2008;21(1):112-4. doi: 10.1016/j.pupt.2007.01.003. Epub 2007 Feb 12. Pulm Pharmacol Ther. 2008. PMID: 17374499 Free PMC article.
-
Survival and prognostic factors in patients with primary pulmonary hypertension.Korean J Intern Med. 2001 Jun;16(2):75-9. doi: 10.3904/kjim.2001.16.2.75. Korean J Intern Med. 2001. PMID: 11590905 Free PMC article.
-
Nitric oxide, oxidative stress and inflammation in pulmonary arterial hypertension.J Hypertens. 2010 Feb;28(2):201-12. doi: 10.1097/HJH.0b013e328332bcdb. J Hypertens. 2010. PMID: 20051913 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical